Price
Target price
?
?
-1.920%
-0.027
-1.920%
€13.55
07:37 / Stuttgart Stock Exchange
WKN: A3DWPS / Symbol: KALA / Name: Kala Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Kala Pharmaceuticals Inc. Stock
We can see a decrease in the price for Kala Pharmaceuticals Inc.. Compared to yesterday it has lost -€0.027 (-1.920%).
With 16 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 1.38 € the target price of 13 € shows a potential of 844.77% for Kala Pharmaceuticals Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Kala Pharmaceuticals Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Unique positioning" there were negative voices in the community.
Pros and Cons of Kala Pharmaceuticals Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Kala Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | -1.920% | 4.701% | -88.160% | -70.513% | -78.214% | -89.755% | -99.626% |
| Krystal Biotech | -1.590% | 4.521% | 22.430% | -1.411% | 3.285% | 119.860% | - |
| Ardelyx Inc. | 1.760% | -5.438% | -20.395% | -20.595% | -10.695% | 177.646% | -9.214% |
| Evolus Inc | -1.890% | 4.950% | -17.188% | -63.946% | -49.524% | -38.728% | 36.986% |
Comments
KALA BIO (NASDAQ:KALA) had its price target raised by analysts at HC Wainwright from $12.00 to $35.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO (NASDAQ:KALA) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $15.00 to $33.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO (NASDAQ:KALA) is now covered by analysts at Mizuho. They set an "outperform" rating and a $30.00 price target on the stock.
Show more
Ratings data for KALA provided by MarketBeat